Has Brian Mayrsohn received payments from drug or device companies?

Yes. Drug and device makers reported $15,758 in general payments to Brian Mayrsohn across 182 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brian Mayrsohn did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brian Mayrsohn come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brian Mayrsohn

Interventional Pain Medicine · Plainview, NYNPI 1023542008

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,367 of the $15,758 with a category attached, or 72.1%. 24 manufacturers reported payments, led by Medtronic at 36.4% of the total.

$15,758in general payments, 2019–2025

Across 182 payments — averaging $86.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$6K
Curonix LLC$2K
Abbott$2K
Boston Scientific$2K
Saluda Medical Americas, Inc.$745
Vertos Medical, Inc.$679
plus $3K from 18 others

What the payments were for

Grants$3,62523%
Travel & lodging$7665%
Food & beverage$11,36772%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	53	$5,734
Curonix LLC	31	$2,080
Abbott	9	$1,723
Boston Scientific	23	$1,563
Saluda Medical Americas, Inc.	12	$745
Vertos Medical, Inc.	5	$679
Globus Medical	6	$584
Nevro Corp.	7	$474
Si-bone, Inc.	3	$394
Relievant Medsystems, Inc.	3	$392
SPR Therapeutics, Inc	5	$242
4web, Inc.	2	$183
MML US, Inc.	2	$179
Spinal Simplicity, LLC	2	$168
Painteq LLC	2	$121
Spinefrontier, Inc.	1	$100
Teva Pharmaceuticals USA, Inc.	3	$81
Axsome Therapeutics, Inc.	2	$65
Vertex	2	$62
AbbVie	3	$50
Valinor Pharma, LLC	2	$49
Avanos Medical	2	$48
Johnson & Johnson	1	$24
Pacira Pharmaceuticals Incorporated	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SYNCHROMEDII$2,500
Intracept$1,500
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$1,305
INTELLIS ADAPTIVESTIM$1,222
Senza$732
mild Device Kit$659
GENERAL PAIN MANAGEMENT$417
PROCLAIM$390
Evoke$352
VANTA ADAPTIVESTIM$333
WaveWriter Alpha Prime 16$300
PRESTIGE LP CERVICAL DISC SYSTEM$159
ReActiv8$144
SPINE TRUSS SYSTEM$138
HA MINUTEMAN G3-R$132
Evoke SCS$127
INCEPTIV$117
SPRINT PNS System$103
InSpan$100
Sacrix$100

How this compares

$15,758 in reported general payments places this provider in the 80th percentile of 132 interventional pain medicine providers in New York.

See all interventional pain medicine providers in New York →

Medicare billing

Part B allowed, 2024

$191,114

Medicare patients

168

Services billed

4,251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	35	$36,899
Naproxen-Esomeprazole MagNaproxen/Esomeprazole Mag	14	$15,493
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	40	$1,162
Oxycodone Hcl	17	$186
Gabapentin	12	$147
Tramadol Hcl	17	$101
Meloxicam	11	$66

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Plainview

Yohan LeePlainview$5K
Araj SidkiPlainview$5K
Corey HunterNew York$446K
Neel MehtaNew York$432K
Hemant KaliaRochester$179K
Martin FerrilloAlbany$164K
George ChaseKew Gardens$102K
Kimberly SackheimNew York$102K
Suelane OuroNew York$68K
Gerard DegregorisNew York$49K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →